ADROPIN- A NOVEL BIOMARKER OF HEART DISEASE: A SYSTEMATIC REVIEW ARTICLE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

YOSAEE SOMAYE; SOLTANI SEPIDEH; SEKHAVATI EGHBAL; JAZAYERI SHIMA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Public Health Year:2016 | Volume:45 | Issue:12 Page(s): 1568-1576

Download Full-Text

View:

216

Download:

Cites:

Information Journal Paper

Title

ADROPIN- A NOVEL BIOMARKER OF HEART DISEASE: A SYSTEMATIC REVIEW ARTICLE

Author(s)

YOSAEE SOMAYE | SOLTANI SEPIDEH | SEKHAVATI EGHBAL | JAZAYERI SHIMA | Issue Writer Certificate

Keywords

ADROPIN

HEART

ENDOTHELIUM

SYSTEMATIC REVIEW

Abstract

Background: HEART disease is one of the most common chronic disease and leading cause of morbidity and mortality worldwide. ADROPIN, a newly identified protein, is important for energy homeostasis and maintaining insulin sensitivity, and has been referred to as a novel regulator of endothelial cells. Endothelial dysfunction is a key early event in atherogenesis and onset of HD. Therefore, this review gives a systematic overview of studies investigating plasma ADROPIN level in patient with HEART disease.Methods: Data carried out in PubMed, Scopus, Web of Science, Embase, Google scholar and MEDLINE, from the earliest available online indexing year through 2015. The search restricted to studies conducted in humans. The key-word search was ADROPIN to apply in title, abstract and keywords. References lists of all original published articles were scanned to find additional eligible studies.Results: HEART failure (HF), coronary atherosclerosis acute myocardial infarction and Cardiac Syndrome X (CSX) were type of HEART disease acknowledged in this study. Majority of evidences introduced low ADROPIN as an independent risk factor of HEART disease. In a case-control study, the plasma level of ADROPIN increased with the severity of HF.Conclusion: ADROPINmay be a potential serum biomarker for early diagnosis of HD.

Cites

No record.

References

No record.

Cite

APA: Copy

YOSAEE, SOMAYE, SOLTANI, SEPIDEH, SEKHAVATI, EGHBAL, & JAZAYERI, SHIMA. (2016). ADROPIN- A NOVEL BIOMARKER OF HEART DISEASE: A SYSTEMATIC REVIEW ARTICLE. IRANIAN JOURNAL OF PUBLIC HEALTH, 45(12), 1568-1576. SID. https://sid.ir/paper/274444/en

Vancouver: Copy

YOSAEE SOMAYE, SOLTANI SEPIDEH, SEKHAVATI EGHBAL, JAZAYERI SHIMA. ADROPIN- A NOVEL BIOMARKER OF HEART DISEASE: A SYSTEMATIC REVIEW ARTICLE. IRANIAN JOURNAL OF PUBLIC HEALTH[Internet]. 2016;45(12):1568-1576. Available from: https://sid.ir/paper/274444/en

IEEE: Copy

SOMAYE YOSAEE, SEPIDEH SOLTANI, EGHBAL SEKHAVATI, and SHIMA JAZAYERI, “ADROPIN- A NOVEL BIOMARKER OF HEART DISEASE: A SYSTEMATIC REVIEW ARTICLE,” IRANIAN JOURNAL OF PUBLIC HEALTH, vol. 45, no. 12, pp. 1568–1576, 2016, [Online]. Available: https://sid.ir/paper/274444/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops